Literature DB >> 14323145

5-METHYLPYRAZOLE-3-CARBOXYLIC ACID. THE POTENT HYPOGLYCEMIC METABOLITE OF 3,5-DIMETHYLPYRAZOLE IN THE RAT.

D L SMITH, A A FORIST, W E DULIN.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS; BLOOD SUGAR; EXPERIMENTAL LAB STUDY; METABOLISM; PHARMACOLOGY; PYRAZOLES; RATS; URINE

Mesh:

Substances:

Year:  1965        PMID: 14323145     DOI: 10.1021/jm00327a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

1.  [Necessity of glucose for long term blockade of the lipolysis with 3,5-dimethylisoxazole and 5-methylpyrazole-3-carboxylic acid].

Authors:  K Sickinger
Journal:  Klin Wochenschr       Date:  1968-05-15

2.  The physiology and pharmacology of adipose tissue lipolysis: its inhibition and implications for the treatment of diabetes.

Authors:  E R Froesch
Journal:  Diabetologia       Date:  1967-12       Impact factor: 10.122

3.  The antilipolytic effects of 3,5-dimethylisoxazole and possible carboxylic acid metabolites.

Authors:  J N Pereira; G F Holland
Journal:  Experientia       Date:  1967-11-15

4.  [Comparison of the effect of insulin and 3,5-dimethylisoxazole on the metabolism of nonesterified fatty acids, glycerine and glucose].

Authors:  U Schwabe; A Hasselblatt
Journal:  Klin Wochenschr       Date:  1966-06-15

5.  In vivo and in vitro antilipolytic effects of some various substituted homocysteine-thiolactone-nicotinamides: structure-activity study.

Authors:  F Maccari; O Ghirardi; P De Witt; M T Ramacci
Journal:  Lipids       Date:  1982-02       Impact factor: 1.880

6.  Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor.

Authors:  Fateme Azimi; Homa Azizian; Mohammad Najafi; Ghadamali Khodarahmi; Lotfollah Saghaei; Motahareh Hassanzadeh; Jahan B Ghasemi; Mohammad Ali Faramarzi; Bagher Larijani; Farshid Hassanzadeh; Mohammad Mahdavi
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.